AstraZeneca continues hunt for RNA-based therapies

04/2/2013 | Bloomberg

AstraZeneca CEO Pascal Soriot is forging ahead with efforts to discover drugs based on RNA technology with its partnership with biotech company Moderna Therapeutics. Moderna's platform allows fast, simultaneous testing on multiple targets for messenger RNA. The company is also working on antisense therapies in partnership with Isis Pharmaceuticals.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC